Rare combination of possessing a clinical stage drug with impressive efficacy, an extensive drug pipeline, a healthy balance sheet while maintaining full rights to all their drugs. With a current enterprise market value of only $44M I believe MEI Pharma has significant upside and could make a big run in 2015.
http://ift.tt/1JgvUw0
http://ift.tt/1JgvUw0
No comments:
Post a Comment